489 related articles for article (PubMed ID: 36159963)
21. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
Jiang F; Liang M; Huang X; Shi W; Wang Y
PeerJ; 2021; 9():e11697. PubMed ID: 34268011
[TBL] [Abstract][Full Text] [Related]
22. RAB11FIP1: An Indicator for Tumor Immune Microenvironment and Prognosis of Lung Adenocarcinoma from a Comprehensive Analysis of Bioinformatics.
Zhang W; Chen T; Liu J; Yu S; Liu L; Zheng M; Liu Y; Zhang H; Bian T; Zhao X
Front Genet; 2021; 12():757169. PubMed ID: 34764984
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
Front Oncol; 2021; 11():633420. PubMed ID: 33747955
[TBL] [Abstract][Full Text] [Related]
24. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
[TBL] [Abstract][Full Text] [Related]
25. Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
Li X; Zhai S; Zhang J; Zhang D; Wang S; Wang L; Yu J
Front Oncol; 2021; 11():698465. PubMed ID: 34195096
[TBL] [Abstract][Full Text] [Related]
26. A more novel and powerful prognostic gene signature of lung adenocarcinoma determined from the immune cell infiltration landscape.
Ma C; Li F; He Z; Zhao S
Front Surg; 2022; 9():1015263. PubMed ID: 36311939
[TBL] [Abstract][Full Text] [Related]
27.
Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H
Front Oncol; 2023; 13():1274439. PubMed ID: 38152367
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K; Ling X; Jiang X; Ma J; Zhu J
Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
[TBL] [Abstract][Full Text] [Related]
29. Identification of
Bian T; Zhang W; Wang F; Chu X; Pan X; Ruan J; Yu S; Liu L; Sun H; Qiu H; Li Y; Tang J; Zhao X; Zhang H
Comb Chem High Throughput Screen; 2023; 26(14):2452-2468. PubMed ID: 37038295
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma.
Li X; Chen J; Meng J
Medicine (Baltimore); 2023 Sep; 102(35):e34557. PubMed ID: 37657044
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration.
Fang C; Zhong R; Qiu C; Zou BB
Front Genet; 2022; 13():833013. PubMed ID: 35281820
[No Abstract] [Full Text] [Related]
32. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
Wang N; Zhu L; Xu X; Yu C; Huang X
Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
[TBL] [Abstract][Full Text] [Related]
33. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration.
Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y
Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483
[TBL] [Abstract][Full Text] [Related]
34. Ribosomal protein L22 like 1: a promising biomarker for lung adenocarcinoma.
Wu Y; Yao N; Du B; Zhu Y; Ji X; Lv C; Lai J
J Cancer; 2024; 15(9):2549-2560. PubMed ID: 38577587
[TBL] [Abstract][Full Text] [Related]
35. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ
Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451
[TBL] [Abstract][Full Text] [Related]
36. LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma.
Jiang X; Chen M; Du J; Bi H; Guo X; Yang C; He X; Jin Z
Front Oncol; 2022; 12():856655. PubMed ID: 35280807
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D
Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma.
Hou Y; Xiang B; Yang Z; Liu J; Xu D; Geng L; Zhan M; Xu Y; Zhang B
Int J Immunopathol Pharmacol; 2023; 37():3946320231202748. PubMed ID: 37731383
[No Abstract] [Full Text] [Related]
39. LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.
Jin X; Chen L; Zhou N; Ni H; Zu L; He J; Yang L; Zhu Y; Sun X; Li X; Xu S
Front Mol Biosci; 2021; 8():711928. PubMed ID: 34901148
[No Abstract] [Full Text] [Related]
40. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
